Tag Archives: Copiktra

Copiktra Side Effects Too Dangerous for Some Cancer Patients, FDA Advisory Committee Decides

September 26, 2022 By: Russell Maas

An FDA advisory committee voted to recommend the agency not approve Copiktra for some blood cancer patients due to an increased risk of death.
Cancer Drug Copiktra Could Shorten Life Expectancy in Some Patients, FDA Reviewers Warn

September 23, 2022 By: Irvin Jackson

An advisory committee is being asked to review the benefits and risks of Copiktra, a blood cancer drug FDA experts say appears to lower life expectancy in some cancer patients.
Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

July 01, 2022 By: Martha Garcia

The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.

Framework for Talcum Powder Science Day Before New MDL Judge Proposed by Parties (Posted 6 days ago)

The new federal judge overseeing all talcum powder lawsuits has called for a Science Day to educate the court ahead of planned Daubert hearings which could decide if bellwether test trials can move forward.

Tepezza Hearing Complaints Known By Drug Maker For Years Before Warnings Provided, According to Lawsuits (Posted 7 days ago)

Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.

Dept. of Justice Outlines Option to Settle Camp Lejeune Lawsuits More Quickly (Posted 13 days ago)

The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.

Tag Archives: Copiktra

Copiktra Side Effects Too Dangerous for Some Cancer Patients, FDA Advisory Committee Decides

Cancer Drug Copiktra Could Shorten Life Expectancy in Some Patients, FDA Reviewers Warn

Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

More Top Stories

Review A Case